Loss of a putative novel growth inhibitory apoptotic 14 kD polypeptide during progression of rat liver carcinogenesis

S S Dadke1, S C Krishnamurthy, K V Rao

  • 1Cellular Carcinogenesis Laboratory, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India. cri3@soochak.ncst.ernet.in

Insights

A novel 14 kD polypeptide, identified in normal rat liver, decreases during liver tumor progression. This reduction is specific to carcinogenesis, not normal regeneration, suggesting it

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Carcinogenesis is a complex, multistep process.
  • Understanding cellular transitions during cancer development is crucial.
  • A novel 14 kD polypeptide with growth inhibitory and apoptotic properties was isolated from normal rat liver.

Purpose of the Study:

  • To investigate the functional relationship between the 14 kD polypeptide and liver carcinogenesis.
  • To examine the sequential expression of the 14 kD polypeptide during tumor progression in a rat liver model.

Main Methods:

  • Diethylnitrosamine (DEN) was used to induce liver carcinogenesis in rats.
  • Immunoperoxidase and immunoblotting techniques were employed.
  • Polyclonal rabbit antisera were used to detect the 14 kD polypeptide.

Main Results:

  • A gradual reduction in 14 kD polypeptide levels was observed with increasing tumor progression.
  • No reduction in 14 kD polypeptide levels was found in regenerating rat liver after partial hepatectomy.
  • The observed reduction was selectively linked to abnormal cell proliferation.

Conclusions:

  • The loss or reduction of the 14 kD polypeptide is associated with abnormal cell proliferation.
  • This polypeptide may serve as a biologically relevant risk factor for hepatocarcinogenesis progression in rats.
  • Further research into the role of this polypeptide in liver cancer is warranted.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...